|
Antibiotic
|
Phenotype (MIC μg/L)
| |
Resistance Genes and Mutations in ST772-MRSA-V
|
|---|
| |
DAR4145
| |
DAR4145
|
07-17048
|
KT/Y21
|
118
|
120
|
333
|
3957
|
3989
|
LVP2
|
VH60
|
|---|
|
Oxacillin
|
R (≥4)
|
mecA
(M)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
blaZ
(M)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
blaZ
(P)
|
+
|
-
|
+
|
+
|
+/−
|
-
|
-
|
+
|
+
|
+
|
|
Gentamicin
|
R (≥16)
|
aacA-aphD
(M)
|
+
|
+
|
+
|
-
|
+
|
+
|
+
|
+
|
+
|
+
|
|
aphA-III, sat4, aadE(p)
(P)
|
+
|
+
|
+
|
+/−
|
+
|
-
|
-
|
+
|
+
|
+
|
|
Trimethoprim/Sulfamethoxazole
|
R (≥320)
|
dfrA
(C)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
dfrG
(C)
|
+
|
-
|
-
|
-
|
+
|
+
|
-
|
+
|
+
|
+
|
|
dfrG
(M)
|
+
|
+
|
+
|
+
|
-
|
-
|
+
|
-
|
-
|
-
|
|
Ciprofloxacin Levofloxacin Moxifloxacin
|
R (4) R (4) I (1)
|
norA/norB
(C)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
grlA
(S80T/F)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
gyrA
(S84L)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
Tetracyline
|
S (≤1)
|
tet(38) (C)
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
+
|
|
Erythromicin Clindamycin
|
I (1) S ( ≤0.25)
|
msrA-mphC
(P)
|
+
|
+
|
+
|
+
|
+
|
-
|
-
|
+
|
+
|
+
|
- (R = Resistant, I = Intermediate, S = Susceptible,C = Chromosomal, M = Mobile Genetic Element, P = Integrated Resistance Plasmid, + = present, − = absent, p = partial, +/− = partial or truncated).
